{"id":"https://openalex.org/W2020787870","doi":"https://doi.org/10.5414/cpp45114","title":"Exenatide effects on statin pharmacokinetics and lipid response","display_name":"Exenatide effects on statin pharmacokinetics and lipid response","alternate_titles":[],"publication_year":2007,"publication_date":"2007-02-01","ids":{"openalex":"https://openalex.org/W2020787870","doi":"https://doi.org/10.5414/cpp45114","mag":"2020787870","pmid":"https://pubmed.ncbi.nlm.nih.gov/17323791"},"language":"en","primary_location":{"id":"doi:10.5414/cpp45114","doi":"https://doi.org/10.5414/cpp45114","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp45114","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020787870"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079794570","display_name":"Prajakti A. Kothare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.A. Kothare","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. kotharep@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. kotharep@lilly.com","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064098013","display_name":"Helle Linnebjerg","orcid":"https://orcid.org/0000-0001-5849-921X","observed_orcids":["https://orcid.org/0000-0001-5849-921X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Linnebjerg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010436601","display_name":"Zachary Skrivanek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z. Skrivanek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014388321","display_name":"Shobha R. Reddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Reddy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058443646","display_name":"Kenneth F. Mace","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Mace","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022493856","display_name":"Amparo de la Pe\u00f1a","orcid":"https://orcid.org/0009-0009-6341-4933","observed_orcids":["https://orcid.org/0009-0009-6341-4933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Pena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068859768","display_name":"Jiyou Han","orcid":"https://orcid.org/0000-0001-5749-3086","observed_orcids":["https://orcid.org/0000-0001-5749-3086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Han","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083503351","display_name":"Mark S. Fineman","orcid":"https://orcid.org/0000-0002-9883-6847","observed_orcids":["https://orcid.org/0000-0002-9883-6847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Fineman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"M. Mitchell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Mitchell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9021,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.91088615,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"45","issue":"02","first_page":"114","last_page":"120"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.5640000104904175,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.5640000104904175,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.25679999589920044,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.09470000118017197,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9409999847412109},{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.796999990940094},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8809999823570251},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6039999723434448},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7749999761581421},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.8690000176429749},{"id":"https://openalex.org/keywords/statin-dose-adjustment","display_name":"statin dose adjustment","score":0.703000009059906},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.8069999814033508}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.937032163143158},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6460590362548828},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6446132063865662},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6425531506538391},{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.6405715346336365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6148121356964111},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6073721051216125},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5697060823440552},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.554779052734375},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4821845591068268},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4539657533168793},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.42439451813697815},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.34513741731643677},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.33573848009109497},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cpp45114","doi":"https://doi.org/10.5414/cpp45114","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp45114","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:17323791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17323791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2315470501","https://openalex.org/W2057670203","https://openalex.org/W2030549264","https://openalex.org/W1998449668","https://openalex.org/W1498903994","https://openalex.org/W2071539395","https://openalex.org/W2102230312","https://openalex.org/W2806398056","https://openalex.org/W2030978667","https://openalex.org/W2001592873"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Exenatide":[1,39],"is":[2,37],"an":[3,69],"adjunctive":[4],"treatment":[5,20],"for":[6,205],"type":[7,13,121],"2":[8,14,122],"diabetes.":[9],"Many":[10],"patients":[11,119,258],"with":[12,21,120,231,259],"diabetes":[15,123],"have":[16],"dyslipidemia,":[17],"which":[18,43],"requires":[19],"three":[22,146],"hydroxy-3-methyl":[23],"glutaryl":[24],"coenzyme":[25],"(HMG-CoA)":[26],"reductase":[27],"inhibitors":[28],"(statins),":[29],"hence,":[30],"concurrent":[31,260],"use":[32],"of":[33,49,78,89,145,265],"exenatide":[34,58,90,130,149,157,197,226,246,266],"and":[35,59,87,95,112,173,180,183,217,227],"statins":[36,60],"likely.":[38],"slows":[40],"gastric":[41],"emptying,":[42],"may":[44],"alter":[45],"the":[46,54,75,85,163,196,225,241],"absorption":[47],"rate":[48],"co-administered":[50],"oral":[51],"medications.":[52],"Thus,":[53,263],"potential":[55],"interaction":[56,244],"between":[57,224],"was":[61,97],"evaluated":[62,98],"in":[63,84,99,109,118,141,237,240,257,271],"two":[64],"study":[65],"settings.":[66],"METHODS:":[67],"In":[68,103,154,195],"open-label,":[70],"fixed-sequence,":[71],"clinical":[72,106],"pharmacology":[73],"study,":[74,245],"plasma":[76,164,175,189],"pharmacokinetics":[77],"lovastatin":[79,160,238],"(40":[80],"mg":[81],"after":[82],"breakfast)":[83],"presence":[86],"absence":[88],"(10":[91],"microg":[92,132],"before":[93],"breakfast":[94],"dinner)":[96],"21":[100],"healthy":[101,155],"subjects.":[102],"a":[104,142],"second":[105],"setting,":[107],"changes":[108,202,236],"lipid":[110,252],"profiles":[111,253],"statin":[113,218,255,261,272],"dosage":[114,219,256],"over":[115],"30":[116],"weeks":[117],"were":[124,220],"retrospectively":[125],"compared":[126],"(n":[127],"=":[128,137],"180":[129],"10":[131],"twice":[133],"daily":[134],"(BID),":[135],"n":[136],"168":[138],"placebo":[139,228],"BID)":[140],"combined":[143],"analysis":[144],"placebo-controlled,":[147],"randomized":[148],"Phase":[150,198],"3":[151,199],"trials.":[152],"RESULTS:":[153],"subjects,":[156],"decreased":[158],"mean":[159],"area":[161],"under":[162],"concentration":[165,176,190],"time":[166,186],"curve":[167],"from":[168,203],"zero":[169],"to":[170,187],"infinity":[171],"(AUC0-infinity)":[172],"maximum":[174,188],"(Cmax)":[177],"by":[178,192],"40":[179],"28%,":[181],"respectively,":[182],"increased":[184],"median":[185],"(tmax)":[191],"4":[193],"hours.":[194],"trials,":[200],"30-week":[201],"baseline":[204],"low-density":[206],"lipoprotein":[207,211],"cholesterol":[208,212],"(LDL-C),":[209],"high-density":[210],"(HDL-C),":[213],"total":[214],"cholesterol,":[215],"triglycerides":[216],"not":[221,248,268],"significantly":[222],"different":[223],"groups":[229],"treated":[230],"statins.":[232],"CONCLUSIONS:":[233],"Despite":[234],"observed":[235],"bioavailability":[239],"pharmacokinetic":[242],"drug":[243],"did":[247],"negatively":[249],"affect":[250],"long-term":[251],"or":[254],"therapy.":[262],"co-administration":[264],"does":[267],"require":[269],"adjustment":[270],"dosage.":[273]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020787870","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
